(8) USAID’s translational research is com-
plementary to the work of other agencies: 
(A) The Quadrennial Development and Di-
plomacy Review (QDDR) proposes to transition 
leadership of the Global Health Initiative (GHI) 
to USAID with a target date of the end of 
2012. A core principle of the GHI is ‘‘Research 
and innovation’’. 
(B) The Presidential Policy Directive on 
Global Development identifies innovation as 
contributing to the resolution of ‘‘long-standing 
development challenges’’. 
(C) The QDDR affirms that ‘‘US leader-
ship in science and innovation is often linked to 
our ability to contribute to a safer, healthier, 
and more stable world.’’. 
SEC. 3. PURPOSES. 
The purpose of this Act is to codify the cooperative 
agreement, known as the Health Technologies program, 
in effect as of the date of the enactment of this Act, under 
which the United States Agency for International Develop-
ment supports the development of technologies for global 
health to— 
(1) improve global health; 
VerDate Mar 15 2010 
02:33 Jun 10, 2011
Jkt 099200
PO 00000
Frm 00007
Fmt 6652
Sfmt 6201
E:\BILLS\H2144.IH
H2144
jbell on DSKDVH8Z91PROD with BILLS
(2) reduce maternal, newborn, and child mor-
tality rates; 
(3) reverse the incidence of HIV/AIDS, malaria, 
tuberculosis, and other infectious diseases; 
(4) reduce the burden of chronic diseases; and 
(5) support research and development that is 
consistent with a global development strategy and 
other related strategies developed by USAID. 
SEC. 4. CODIFICATION OF HEALTH TECHNOLOGIES PRO-
GRAM. 
Section 107 the Foreign Assistance Act of 1961 (22 
U.S.C. 2151e) is amended by adding at the end the fol-
lowing: 
‘‘(c) HEALTH TECHNOLOGIES PROGRAM.—(1) There 
is established in the United States Agency for Inter-
national Development (USAID) a health technologies pro-
gram (referred to in this subsection as the ‘program’). 
‘‘(2) The program shall develop, advance, and intro-
duce affordable, available, and appropriate and primarily 
late-stage technologies specifically designed to— 
‘‘(A) improve the health and nutrition of popu-
lations in developing countries; 
‘‘(B) reduce maternal, newborn, and child mor-
tality in such countries; and 
VerDate Mar 15 2010 
02:33 Jun 10, 2011
Jkt 099200
PO 00000
Frm 00008
Fmt 6652
Sfmt 6201
E:\BILLS\H2144.IH
H2144
jbell on DSKDVH8Z91PROD with BILLS
‘‘(C) improve the diagnosis, prevention, and re-
duction of disease, especially HIV/AIDS, malaria, 
tuberculosis, and other infectious diseases, in such 
countries. 
‘‘(3) The program shall be carried out under a coop-
erative agreement between USAID and one or more insti-
tutions with a successful record of— 
‘‘(A) advancing the technologies described in 
paragraph (2); and 
‘‘(B) integrating practical field experience into 
the research and development process in order to in-
troduce the most appropriate technologies. 
‘‘(4) The provisions of this subsection codify the coop-
erative agreement, known as the Health Technologies pro-
gram, in effect as of the date of the enactment of this 
subsection, under which USAID supports the development 
of technologies for global health. The provisions of this 
subsection do not establish a new cooperative agreement 
or program for such purposes.’’. 
SEC. 5. REPORT ON RESEARCH AND DEVELOPMENT AC-
TIVITIES AT USAID. 
(a) IN GENERAL.—The Administrator of the United 
States Agency for International Development (referred to 
in this subsection as ‘‘USAID’’) shall submit to Congress 
VerDate Mar 15 2010 
02:33 Jun 10, 2011
Jkt 099200
PO 00000
Frm 00009
Fmt 6652
Sfmt 6201
E:\BILLS\H2144.IH
H2144
jbell on DSKDVH8Z91PROD with BILLS
an annual report on research and development activities 
at USAID. 
(b) MATTERS TO BE INCLUDED.—The report re-
quired by subsection (b) shall describe— 
(1) updates on its strategy for using research 
funds to stimulate the development and introduction 
of key products; 
(2) USAID’s collaborations and coordination 
with other Federal departments and agencies in sup-
port of translational and applied global health re-
search and development; 
(3) its investments for the fiscal year in science, 
technology, and innovation; 
(4) how these technologies and research prod-
ucts complement the work being done by other Fed-
eral departments and agencies, if applicable; and 
(5) technologies and research products that 
have been introduced into field trials or use. 
Æ 
VerDate Mar 15 2010 
02:33 Jun 10, 2011
Jkt 099200
PO 00000
Frm 00010
Fmt 6652
Sfmt 6301
E:\BILLS\H2144.IH
H2144
jbell on DSKDVH8Z91PROD with BILLS